Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Omeprazole on Tapentadol IR Pharmacokinetics
NCT03979989Phase 1Completed
- Sponsor
- Grünenthal GmbH
- Start
- Sep 2005
- Primary completion
- Nov 2005
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tapentadol in pain (2 arms), sponsored by Grünenthal GmbH. Primary endpoints: Maximum Serum Concentration of Tapentadol at 48 hours, Area Under the Serum Concentration-Time Curve from Time Zero to Time t at 48 hours and 1 more. Started Sep 2005; status: completed.
02
Drugs
tapentadol
03
Conditions
pain
Beyond the preview
Go deeper on NCT03979989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03979989.